OR WAIT null SECS
Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity
Catalent has reached an agreement to acquire Metrics Contract Services, a full-service specialty contract development and manufacturing organization (CDMO), for $475 million from Mayne Pharma Group Limited. The company will strengthen its capabilities in integrated oral solid formulation development, manufacturing, and packaging, as well as expand its capacity to handle highly potent compounds upon completion of the acquisition.
The deal will also include the CDMO's 333,000 square-foot facility located in Greenville, NC. The facility features comprehensive capabilities to accelerate and de-risk customer programs, from early development through commercial launch via a streamlined one-site solution.
“This acquisition will further expand Catalent’s ability to meet our customers’ expectations in fast-growing areas of the business and patient need. The experienced team and consistently improved, state-of-the-art facility in Greenville will provide Catalent’s customers with immediate, fit-for-scale capacity for in-demand highly potent drugs and other oral solid small-to-mid-size batch needs,” says Aris Gennadios, PhD, group president of Catalent’s Pharma & Consumer Health segment. “This capacity is particularly important for customers with R&D pipelines, featuring accelerated, orphan, and rare disease programs for oncology and other important therapeutic areas.”